Home > Healthcare > Biotechnology > Biotechnology R&D > Mycoplasma Testing Market

Mycoplasma Testing Market Share

Report ID: GMI8300
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Mycoplasma Testing Market Share

The mycoplasma testing industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Thermo Fisher Scientific Inc. among others have a notable presence in the market.

Mycoplasma Testing Market Companies

Some of the eminent market participants operating in the mycoplasma testing industry include:

Becton, Dickinson, and Company (BD)
Bio-Rad Laboratories, Inc.
Charles River Laboratories International, Inc.
Creative Bioarray
Eurofins Scientific
InvivoGen
Lonza Group AG
Merck KGaA
Minerva Biolabs GmbH
PromoCell GmbH
QIAGEN N.V.
Sartorius AG
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market size for mycoplasma testing was valued at around USD 909.5 Million in 2023 and is estimated to reach over USD 2.5 billion by 2032, driven by the rising contamination rate and increasing R&D activities.

Kits & reagents segment held a robust market share in 2023 and is estimated to account for USD 1.4 billion by 2032, owing to their pivotal role in mycoplasma testing, offering standardized protocols, streamlined workflows, and increased accuracy.

North America mycoplasma testing industry held a significant revenue share of 40.6% in 2023 and is predicted to witness substantial growth through 2032, driven by increasing government investment to produce new active pharmaceutical ingredients (APIs).

Becton, Dickinson, and Company (BD), Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Creative Bioarray, Eurofins Scientific, InvivoGen, Lonza Group AG, Merck KGaA, Minerva Biolabs GmbH, PromoCell GmbH are some of the major industry contenders.